OrphanDrug
OrphanDrug
Pharma Knowledge Base

deafness dystonia syndrome

MeSH: C535808ORPHA: 3213

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Classification & Codes

Overview

mitochondrial metabolism disease that is characterized by hearing loss that begins early in life, problems with movement, impaired vision, and behavior problems

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Classification & Codes

MeSH Code

C535808

Orphanet Code

ORPHA:3213
deafness dystonia syndrome
MeSHC535808
OrphanetORPHA:3213
Treatments0 drug(s)
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO